An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome

Changes in mGlu5 Receptor-Dependent Synaptic Plasticity and Coupling to Homer Proteins in the Hippocampus of Ube3A Hemizygous Mice Modeling Angelman Syndrome

(2014) M. Pignatelli et al.   JOURNAL OF NEUROSCIENCE

Minocycline: far beyond an antibiotic

(2013) N Garrido-Mesa et al.   BRITISH JOURNAL OF PHARMACOLOGY

Low glycemic index treatment for seizures in Angelman syndrome

(2012) Ronald L. Thibert et al.   EPILEPSIA

Analysis of EEG patterns and genotypes in patients with Angelman syndrome

(2012) Martina Vendrame et al.   EPILEPSY & BEHAVIOR

The Two Different Effects of the Potential Neuroprotective Compound Minocycline on AMPA-Type Glutamate Receptors

(2012) Ling-Jing Jin et al.   PHARMACOLOGY

Decreased Tonic Inhibition in Cerebellar Granule Cells Causes Motor Dysfunction in a Mouse Model of Angelman Syndrome

(2012) K. Egawa et al.   Science Translational Medicine

A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome

(2011) Lynne M. Bird et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Common data elements in epilepsy research: Development and implementation of the NINDS epilepsy CDE project

(2011) David W. Loring et al.   EPILEPSIA

Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density

(2011) J. T. Rogers et al.   LEARNING & MEMORY

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

(2011) Hsien-Sung Huang et al.   NATURE

Adeno-Associated Virus-Mediated Rescue of the Cognitive Defects in a Mouse Model for Angelman Syndrome

(2011) Jennifer L. Daily et al.   PLoS One

Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid

(2010) Sarika U. Peters et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

The behavioral phenotype of the Angelman syndrome

(2010) Charles A. Williams   AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS

Open-label add-on treatment trial of minocycline in fragile X syndrome

(2010) Carlo Paribello et al.   BMC Neurology

EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse Formation

(2010) Seth S. Margolis et al.   CELL

The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc

(2010) Paul L. Greer et al.   CELL

‘Puppet’ Children A Report on Three Cases

(2010) Harry Angelman   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient mice

(2010) Hu Chen et al.   NEUROPHARMACOLOGY

Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALS

(2009) Hari Manev et al.   Amyotrophic Lateral Sclerosis

Angelman Syndrome Scientific Symposium on the Structure and Function of UBE3A/E6AP

(2009) Charles Williams   JOURNAL OF CHILD NEUROLOGY

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

(2007) Yuko Fujita et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Epilepsy in Angelman syndrome

(2007) Karine Pelc et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY